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Interleukin-1 system in the human fallopian tube -no spatial but 
Introduction
The factors involved in the complex embryonic maturation and in the embryo-45 maternal dialogue resulting in eutopic embryonic implantation are poorly understood.
The human fallopian tube is the place of fertilization and also provides the natural environment for the first five days of embryonic development (Hess et al., 2007b) . It is, as well, the most common place for ectopic implantation. The preimplantation embryo produces several factors during its development to signal its presence to the 50 maternal organism. Appropriate interaction between the preimplantation embryo and the maternal system is at least partly controlled by paracrine cytokines (Hess et al., 2007a; Popovici et al., 2006) . Knowledge of expression patterns of these cytokines could possibly help to gain a better insight of the physiological course of implantation. Although multiple studies have examined the existence and influence of 55 various cytokines at the embryonic-maternal interface (Hess et al. 2007a; Popovici et al., 2006) , as yet, little is known about cytokine production by the human fallopian tube (Brabec and Hill, 2000) .
The Interleukin-1-system is composed of two agonists, and Interleukin-1 (IL-1), one antagonist, the Interleukin-1 receptor antagonist (IL-60 1ra) and two membrane-bound receptors, Interleukin-1 receptor type I (IL-1R tI) and II (IL-1R tII) (Dinarello et al., 1994; Dimitriadis et al., 2005) . All components of the IL-1 family in humans are located on chromosome 2 and the DNA-, RNA-and protein-structures are all well characterized for many species. Both agonists are initially synthesized as precursor proteins of 31 kDa. The mature proteins have a 65 molecular weight of 17 kDa and although the amino acid sequences have a similarity A c c e p t e d M a n u s c r i p t
Interleukin-1 system in human fallopian tube page 5 of only ~22 %, they induce the same biological responses (Dower et al., 1986) . There is also a high similarity between the cDNA-sequences of IL-1 and - in mice and human (March et al., 1985) . Interleukin-1 receptors type I and II both possess a transmembraneous domain and their extracellular portions are homologous with 70 similar binding affinities for the agonists and antagonist. There is also a soluble form of the IL-1R tII. The IL-1 receptor type I wich is found in low numbers on almost all cell surfaces whereas IL-1R tII is found primarily on white blood cells. Only the binding of either IL-1 or - to the IL-1 receptor type I results in signal transduction with receptor type II and the soluble IL-1 receptor acting as 75 competitors of the receptor type I . The IL-1 receptor antagonist binds with a high affinity to both receptors and prevents signal transduction by IL-1 and - (Hannum et al., 1990 ).
The IL-1 system is intimately involved in embryonic implantation. In humans, the IL-1R tI has been detected in total human endometrium (Simon et al., 1993b) and, more 80 specifically, in endometrial epithelial cells with a maximum mRNA-and proteinexpression during the luteal phase (Simon et al., 1993a ) -the time of embryonic attachment and implantation. IL-1-mRNA was detected in secretory human endometrium beginning on day 23 of the menstrual cycle (Kauma et al., 1990) . In the last years, all major components of the IL-1-system, namely IL-1, IL-1ra and IL-1R 85 tI were detected immunohistochemically in single preimplantation embryos (De Los Santos et al., 1996) . In vitro fertilized, cultured human embryos have been shown to produce both IL-1 and IL-1 High concentrations [>60 pg/ml and >80 pg/ml] of these cytokines in culture media have been correlated with successful implantation M a n u s c r i p t could not detect IL-1 or - in culture fluids of human embryos (Seifer et al., 1993) .
In mice, IL-1 and IL-1 have been detected and localized at mRNA-and proteinlevel in endometrial endothelial cells (Tackacs et al., 1988) in increasing levels from day 3 of pregnancy peaking between days 4 and 5 (De et al., 1993) . Blastocyst implantation is known to occur late on day 4. It was shown that systemically 95 administered recombinant human IL-1ra given intraperitoneally from day 3 to day 6 of pregnancy inhibited embryonic implantation in mice (Simon et al., 1994a) . It was also demonstrated that in vitro cultured single mouse embryos at various stages of preimplantation development express different patterns of mRNA for IL-1, IL-1ra and IL-1R tI (Simon et al., 1994b) . 100
In summary, there is an increasing body of evidence that the IL-1 system is involved in early embryonic development and implantation. The aim of our study was to detect a potentially spatial and temporal IL-1-, IL-1ra-and IL-1R tI-expression pattern on mRNA-and protein-level in human fallopian tubes and to describe possible hormonally regulated changes since these changes might influence the time and place 105 of embryonic implantation.
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Material and Methods

Patients
Patients who underwent hysterectomy or tubal surgery for reasons other than 110 cancer (except one patient with intrauterine pregnancy diagnosed of cervical cancer) were asked to participate in this study. Each participating patient signed an informed consent that was prior approved by the human investigations committee of the Heinrich-Heine University medical school. Menstrual phase was determined by the patient's history and dating was verified by histological examination of the 115 endometrium according to Noyes et al. (1950) and serum-levels of estradiol, progesterone, LH and FSH were measured. The indications for surgery were as follows: hysterectomy for benign reasons: 19 patients; ectopic tubal pregnancies: 3 patients and one patient received a radical hysterectomy in the 9 th week of gestation due to cervical cancer. The mean age of the patients was 39 ± 7.9 yr, range 26 -51 yr. 120
Tissue samples from the fimbrial, ampullary and isthmic parts of the fallopian tubes were collected from both sides. Tissue samples were than split in half: one half was fixed in 4 % paraformaldehyde and later processed for immunohistochemistry, the other half was snap-frozen in liquid nitrogen and stored at -80 °C until RNAextraction. 125
RNA isolation
The isolation of RNA from the tissue samples was done as described previously (Chomczynski and Sacchi, 1987) with the RNA-STAT-60 reagent (TelTest "B" Inc., Friedenswood, TX, USA). Briefly, tissue samples were washed threeM a n u s c r i p t 
Primers for Reverse Transcription (RT) and Polymerase Chain Reaction (PCR) 140
Sequences of cDNA-clones for the mRNAs that should be detected in human fallopian tubes (-actin, IL-1, IL-1ra and IL-1R tI) were obtained from the GenBank http://www.ncbi.nlm.nih.gov/sites/entrez). One set of primer-sequences was found 145 with the help of the program OLIGO 4.1 Primer Analysis Software (National Bioscience, Plymouth, MN, USA) and synthesized by MWG Biotech (MWG Biotech AG, Ebersberg, Germany). To ensure that the product detected resulted from amplification of cDNA rather than contaminating genomic DNA, primers were designed to cross intron/exon boundaries. The human -actin primers that were used 150 to amplify an internal standard were obtained from Clontech Laboratories Inc., Palo Alto, CA, USA. The primer-sequences, locations on the cDNA and the sizes of the amplified fragments are listed in Table 1 .
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Reverse transcription (RT) 155
For each mRNA to be detected, 20 µl RT-MasterMix were prepared (5 mM completion of electrophoresis, the agarose-gel was analyzed on the GelDoc 1000 system (Bio-Rad Laboratories, Hercules, CA, USA). DNA-size calculation was carried out by using the Molecular Analyst Software (Bio-Rad Laboratories).
180
Immunohistochemical staining procedure
The immunostaining procedure was performed on fallopian tubes sections by the avidin-biotin-peroxidase (ABC) method. Serial sections from each sample were mounted on slides, fixed in formalin and embedded in paraffin. The first section was processed for hematoxylin-eosin staining. 185
Sections were deparaffinized in xylene, rehydrated through graded alcohols, and washed in phosphate-buffered saline (PBS; Sigma). Endogenous peroxidases were blocked with 1% H 2 O 2 in 96% methanol, and non-specific binding was blocked with non-fat milk 5% in PBS at room temperature. After washing with 0.05% Tween M a n u s c r i p t
RT-PCR of spatial expression pattern throughout the menstrual cycle
All 19 collected oviduct samples from the proliferative (n=8) and secretory (n=9) phase of the cycle and postmenopausal (n=2) women were divided into fimbrial, ampullary and isthmic parts and investigated separately by RT-PCR. From the total of 19 samples all were positive for β-actin mRNA expression and therefore 215 considered for further investigation. The following investigation of IL-1β, Il-1ra and Il-1R tI expression showed that the presence or absence of the respective gene was constant regarding the spatial distribution. This shows that the gene expression of IL-1β, Il-1ra and Il-1R tI within the length of the fallopian tube has no spatial difference (Fig. 1) . 220
RT-PCR of temporal expression pattern throughout the menstrual cycle
All 23 collected oviduct samples from the proliferative (n=8) and secretory (n=9) phase of the cycle and from postmenopausal (n=2) women and extra-(n=3) and intrauterine (n=1) pregnancies were separately investigated by RT-PCR for temporal 225 expression patterns of IL-1β, IL-1ra and IL-1R tI. From the total of 23 samples, all were positive for β-actin mRNA expression and therefore considered for further investigation. The following investigation of IL-1β, Il-1ra and Il-1R tI expression showed that there was a temporal and therefore most likely hormonal regulation of two of the target mRNAs. IL-1R tI was expressed in all samples regardless the 230 hormonal situation. IL-1ra mRNA could be detected in samples of the secretory phase and in intrauterine pregnancy, whereas IL-1β could be detected in proliferative and M a n u s c r i p t
Interleukin-1 system in human fallopian tube page 13 secretory phase fallopian tubes and in samples of intra-and extra-uterine pregnancy.
This shows that the gene expression of IL-1β, Il-1ra and Il-1R tI is temporally regulated within the human cycle ( Fig. 1 and 2 ). Additionally IL-1β is expressed not 235 only in all different hormonal situations investigated but also in oviducts from intraand extrauterine pregnancies.
Immunohistochemistry
The protein expression of IL-1β, Il-1ra and Il-1R tI of proliferative phase 240 versus secretory phase samples was evaluated using immunohistochemistry. show a strong expression of IL-1β foremost in the luminal epithelium and also in the small vessels endothelium of secretory phase oviducts (Fig. 3 C, D) , whereas the staining for IL-1β in the luminal epithelium of proliferative phase oviducts was less intense and only a weak staining was localized in the small vessels endothelium (Fig.  250 3 K, L). The IL-1R tI was shown to be expressed in the luminal epithelium, small vessels endothelium and glandular epithelium of secretory phase samples (Fig. 3 E,   F ). In comparison the proliferative sample showed only a sporadic staining for the IL-1R tI in the luminal epithelium and no staining either in the vessel endothelium or in the glandular epithelium (Fig.3 M, N) . Fig. 3 G and H show an intense staining of ILM a n u s c r i p t
Interleukin-1 system in human fallopian tube page 14 1ra in the luminal epithelium and the small vessel endothelium of secretory phase oviducts whereas a staining for IL-1ra in proliferative oviducts was completely absent revealing a strict temporal expression of IL-1ra.
No staining was observed in the absence of either primary or secondary antibodies.
These protein data support the previous mRNA data showing an expression of 260
Il-1β in fallopian tubes of both cycle phases with an increase in the secretory phase as well as a pronounced expression of IL-1R tI in secretory phase oviducts. However, IL-1ra expression was seen in secretory phase samples only.
M a n u s c r i p t
Factors of the embryo-maternal communication that have an influence on maturation and transport of an embryo as it transverses the oviducts are crucial for a successful implantation (Hess et al., 2007a) . The fallopian tube on the maternal side plays an important role in providing the place for fertilization as well as an active component for transport and early development of the embryo. Within the oviduct, 270 remarkable changes occur in dependence to the sex steroids estradiol in the proliferative phase and progesterone in the post-ovulatory secretory phase indicating a hormonal cyclicity of the oviduct comparable to the endometrium (Gardner et al., 1996) . A growing body of evidence suggests that chemokines of the IL-1 family play an important role at the feto-maternal interface (Krussel et al., 2003) . Therefore, the 275 knowledge of normal expression patterns of the IL-1 family members could help in understanding the physiological processes leading to proper maturation and transport of the blastocyst within the fallopian tube and subsequently to a successful intrauterine implantation. Since we have shown before that the human embryo produces IL-1β when cultured in vitro (Krussel et al., 1998) , it is reasonable that it 280 also produces IL-1 β during its passage through the fallopian tube. Consequently, it is very likely that the fallopian tube as the early communication partner for the developing embryo itself expresses components of the IL-1 family. Therefore, our objective was to first investigate the spatial expression pattern of IL-1β, Il-1ra and Il-1R tI in the human fallopian tube and second to elucidate a possible hormonal 285 influence. Furthermore we wanted to explore whether we could find a hint for an All collected oviduct samples from the proliferative and secretory phase of the cycle as well as the postmenopausal samples were divided into fimbrial, ampullary and 290 isthmic parts before investigation and prepared separately. This led us to the observation that regardless of the original spatial belonging of the oviduct part, the mRNA expression of IL-1β, Il-1ra and Il-1R tI showed no differences at all. These findings on the mRNA level were also proven on the protein level by immunohistochemistry (data not shown). The data support the notion that although 295 the oviduct is compromised of a changing architecture within its full length, the molecular base of gene expression remains the same in all parts of the fallopian tube.
Therefore, possible differences in gene expression regarding to the biopsy technique are erased which makes studies involving different parts of the oviduct comparable. Furthermore, our aim was to elucidate whether the sex steroids estrogen and 300 progesterone have an influence on the temporal expression of IL-1β, Il-1ra and Il-1R tI during the reproductive phase. Therefore, fallopian tubes from the proliferative and secretory phase of the menstrual cycle as well as oviducts from postmenopausal women were investigated. This showed that IL-1β was only present in samples from the proliferative and secretory phase but in none of the postmenopausal oviducts 305 suggesting a regulation by sex steroids and a role in the process of human reproduction. These data highlight that the oviduct and the uterus underlie partially common most likely hormonally driven regulatory expression phenotypes since a study has shown that IL-1β is expressed as well by epithelial and stromal M a n u s c r i p t
Interleukin-1 system in human fallopian tube page 17 endometrium cells throughout the cycle (Simon et al., 1993a) . In unison with our 310 immunohistochemistry results they detected an increase of IL-1β immunostaining from proliferative to secretory endometrium suggesting an additional role in supporting the implantation within the endometrium during the window of implantation. On the contrary, another study primarily focused on the expression of Il-1α by endometrial stromal cells reports a hormonally controlled expression of IL-315 1α but not for IL-1β or Il-1ra (Pretto et al., 2008) . Furthermore, it was shown that incubation of endometrial stromal cells with IL-1β upregulates the expression of IL-1β and IL-1ra (Huang et al., 2001) suggesting that besides a hormonal regulation chemokines seem to influence the expression of Il-1 family members in endometrial stromal cells which could be likewise for the tube. In addition an 320 immunohistochemical approach revealed IL-1β staining in the villous cytotrophoblast, syncytiotrophoblast and maternal decidual cells, suggesting an autocrine/paracrine role during the human implantation (Simon et al., 1994b) . In contrast to the ligand, we detected mRNA expression of its receptor IL-1R tI in all samples investigated. The immunostaining showed a less intense staining in 325 proliferative phase samples compared to secretory phase oviducts suggesting at least a moderate influence of the sex hormones. Furthermore it provides new evidence that the preimplantation embryo is able to communicate with the maternal side already during its transit through the fallopian tube by its own IL-1β secretion in consent to a study by Strakova et al. (2005) simulating endometrial changes of an early pregnancy 330 in baboons by in vivo infusion of hCG and IL-1β.
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In contrast, IL-1ra mRNA was only detected in progesterone dominated secretory phase samples and in the intrauterine pregnancy sample suggesting a hormonal influenced regulation and further a possible protection mechanism to avoid a false implantation of the embryo within the fallopian tube. The IL-1ra expression seems to 335 be a rather systemic effect independent of the embryos presence since it was equally expressed in both sides of the fallopian tubes of each patient in the secretory phase. IL-1ra's possible protective effect becomes even more likely in the context that IL1ra was not only present in all secretory phase samples and the one investigated sample with an intrauterine pregnancy but did not occur in anyone of the 3 tested 340 fallopian tubes with an extrauterine pregnancy. This hypothesis is furthermore supported by findings of other groups describing a decrease in IL-1ra expression in the human endometrium at the time of implantation to possibly facilitate the embryos invasion into the maternal endometrium (Simon et al., 1995) . Another study showed increased levels of IL-1ra in endometrial stromal cells of the secretory phase (Fukuda 345 et al., 1995) . Those differences though might be explained by the fact that the first study investigated the mRNA and protein expression for secreted IL-1ra and intracellular IL-1ra whereas the second study did not differentiate between those two forms. The findings of the first study positively correlate with a study in mice where systemically administered IL-1ra prevented embryonic implantation (Simon, 1994a) . 350
However, this distinct inhibition of implantation might have been a mouse strain specific effect as a study by Abbondanzo et al. (1996) Based on those findings in human as well as in the animal studies the IL-1β system appears to be involved in the establishment of pregnancy although the exact magnitude is still questionable due to the conflicting data in the literature. 385
Furthermore, rigorous species specific differences might attribute to an inconsistency in the importance of the IL-1 system in implantation as well.
To our knowledge this is the first study to report that the gene expression profile is not altered within the different anatomical parts of the fallopian tube showing a constant gene expression pattern of all IL-1β system factors throughout the complete 390 length of the oviduct investigated. Additionally, the restricted IL-1ra expression in secretory phase fallopian tubes and absence in extrauterine pregnancy tube samples might be an important mechanism on the molecular base to prevent ectopic pregnancies within the oviduct which needs further investigation. The finding that IL-1R tI is expressed in both cycle phases independent of a pregnancy in addition to the 395 embryos own IL-1β expression supports the concept of an early embryo-maternal dialogue facilitating a proper implantation process. M a n u s c r i p t
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Figure Legends 
